Procept Biorobotics Corp
PRCT
View Detailed Chart
34.260USD
+2.200+6.86%
Close 12/22, 16:00（ET）Quotes delayed by 15 min
1.91BMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+6.86%
5 Days
-5.10%
1 Month
+14.74%
6 Months
-43.11%
Year to Date
-57.45%
1 Year
-57.79%
View Detailed Chart
TradingKey Stock Score of Procept Biorobotics Corp
Currency: USD Updated: 2025-12-19Key Insights
Procept Biorobotics Corp's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 40/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 52.18.In the medium term, the stock price is expected to trend down.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Procept Biorobotics Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
13
analysts
Buy
Current Rating
52.182
Target Price
+53.34%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Procept Biorobotics Corp Highlights
StrengthsRisks
PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 199.27% year-on-year.
Fairly Valued
The company’s latest PE is -20.91, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 55.75M shares, decreasing 2.90% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 1.08K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.66.
Procept Biorobotics Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Procept Biorobotics Corp Info
PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.
Ticker SymbolPRCT
CompanyProcept Biorobotics Corp
CEOWood (Larry L)
Websitehttps://www.procept-biorobotics.com/
FAQs
What is the current price of Procept Biorobotics Corp (PRCT)?
The current price of Procept Biorobotics Corp (PRCT) is 34.260.
What is the symbol of Procept Biorobotics Corp?
The ticker symbol of Procept Biorobotics Corp is PRCT.
What is the 52-week high of Procept Biorobotics Corp?
The 52-week high of Procept Biorobotics Corp is 89.490.
What is the 52-week low of Procept Biorobotics Corp?
The 52-week low of Procept Biorobotics Corp is 27.800.
What is the market capitalization of Procept Biorobotics Corp?
The market capitalization of Procept Biorobotics Corp is 1.91B.
What is the net income of Procept Biorobotics Corp?
The net income of Procept Biorobotics Corp is -91.41M.
Is Procept Biorobotics Corp (PRCT) currently rated as Buy, Hold, or Sell?
According to analysts, Procept Biorobotics Corp (PRCT) has an overall rating of Buy, with a price target of 52.182.
What is the Earnings Per Share (EPS TTM) of Procept Biorobotics Corp (PRCT)?
The Earnings Per Share (EPS TTM) of Procept Biorobotics Corp (PRCT) is -1.533.
Related Instruments
-0.68%
-0.20%
+1.37%
+1.29%
+1.43%
+0.86%
+0.35%
-0.93%
-0.19%
+0.78%
+1.07%
+1.35%
-0.31%
+0.25%
+0.59%
+0.99%
+0.74%
+0.93%
+1.27%
+0.65%Popular Symbols
